Study on the Safety of Risperidone on Obese or Overweight Patients With Schizophrenia

Stopped Due to the achievement of minimum required sample size and new changes in local regulations.

Conditions

• Schizophrenia
• Schizoaffective Disorder
• Schizophreniform Disorder

Interventions

• DRUG: Risperidone

Sponsor

Janssen-Cilag, S.A.